Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin D1

Blood

Volumn 88, Issue 1, 1996, Pages 268-276

  Zukerberg, Lawrence R ^b   Benedict, William F ^b   Arnold, Andrew ^b   Dyson, Nicholas ^b   Harlow, Edward ^b   Harris, Nancy Lee ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLINE; RETINOBLASTOMA PROTEIN;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GERMINAL CENTER; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030014469     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.268.268     Document Type: Article

References (53)

1. Weinberg RA: Tumor suppressor genes. Science 254:1138, 1991
2. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Penica-Worins H, Huang CM, Livingston DM: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell58:1085, 1989
3. Goodrich DW, Wang NP, Qian Y-W, Lee EY-HP, Lee W-H: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell67:293, 1991
4. Helin K, Lees JA, Vidai M, Dyson N, Harlow E, and Fattaey A: A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell70:337, 1992
5. Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Aschenbaum F, Fuchs CS, Crittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK: Expression of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell70:351, 1992
6. Nevins JR: E2F; a link between the Rb tumor supressor protein and viral oncoproteins. Science 258:424, 1992
7. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E: Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124, 1988
8. Fattaey AR, Harlow E, Helin K: Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol 13:7267, 1993
9. Meyerson M, Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077, 1994
10. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY: D-type cyclin-dependent kinase activity im mammalian cells. Mol Cell Biol 14:2066, 1994
11. Motokura T, Arnold A: Cyclin D and oncogenesis. Curr Opin Genet Dev 3:5, 1993
12. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell70:993, 1992
13. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with Human D cyclins. Cell73:499, 1993
14. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled anitbody (PAP) procedures. J Histochem Cytochem 29:577, 1981
15. Harris NL, Jaffe ES, Stein H, Banks PM, Chan J, Cleary ML, Delsol G, DeWolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Pinis MA, Ralfkiaer E, Warnke RA: A revised EuropeanAmerican classification of lymphoid neoplasms: A proposal from the international study group. Blood 84:1361, 1994
16. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL: Cyclin D1 (Bcl-1, PRADI) protein expression in low-grade-B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86, 1994
17. Zukerberg LR, Yang WI, Arnold A, Harris NL: Cyclin D1 expression in non-Hodgkin's lymphomas: detection by immunohistochemistry. Am J Clin Pathol 103:756, 1995
18. Xu HJ, Hu SX, Benedict WF: Lack of nuclear RB protein staining in GO/middle G1 cells: Correlation to changes in total RB protein level. Oncogene 6:1139, 1991
19. Cordon-Cardo C, Richon VM: Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol 144:500, 1994
20. Tsai LH, Delalle I, Caviness VS, Chae T, Harlow E: P35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419, 1994
21. Hu Q, Bautista C, Edwards G, Defeo-Jones D, Jones R, Harlow E: Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol 11:5792, 1991
22. Tsai LH, Lees E, Faha B, Harlow E, Riabowlo K: The cdk2 kinase is required for G1-to-S transition in mammalian cells. Oncogene 8:1593, 1993
23. Harlow E, Crowford LV, Pim DO, Williamson NM: Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol 39: 861, 1981
24. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell71:1, 1992
25. Hu Q, Dyson N, Harlow E: The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J 9:1147, 1990
26. Ginsberg AM, Raffeld M, Cossman J: Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 77:833, 1991
27. Newcomb EW, Thomas A, Selkirk A, Lee SY, Potmesil M: Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation. Can Res 55:2044, 1995
28. Kornblau SM, Chen N, Giglio AD, O'Brien S, Deisseroth AB: Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res 54:242, 1994
29. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812, 1993
30. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel M, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559, 1993
31. Schauer IE, Siriwardana S, Langan TA, Sclafani RA: Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA 91:7827, 1994
32. Buchkovich K, Duffy LA, Harlow E: The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097, 1989
33. Chen LP, Scully P, Shew JY, Wang J, Lee WH: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell58:1193, 1989
34. Mihara K, Cao XR, Yen A, Chandler S, Driscol B, Murphee AL, T'ang A, Fung YKT: Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300, 1989
35. Chellappan S, Hiebert S, Mudryi M, Horowitz J, Nevins J: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053, 1991
36. Akiyama T, Ohuchi T, Sumida S, Matsumoto K, Toyoshima K: Phosphorylation of the retinoblastoma protein by cdk2. PNAS 89:7900, 1992
37. Lees JA, Buchkovich KJ, Marshak DR, Anderson CW, Harlow E: The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J 10:4279, 1991
38. DeCaprio JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston D: The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. PNAS 89:1795, 1992
39. Furukawa Y, Piwnica WH, Ernst TJ, Kanakura Y, Griffin JD: Cdc2 gene expression at the G1 to S transition in higher eukaryotes. Science 250:805, 1990
40. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. PNAS 91:709, 1994
41. Zukerberg LR, Medeiros LJ, Ferry JA, Harris NL: Diffuse low-grade B-cell lymphomas. four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Path 100:373, 1993
42. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D1/cdk4. Nature 366:704, 1993
43. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocken E, Day RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 263:436, 1994
44. Matsuoka S, Yamaguchi M, Matsukage A: D-type cyclin binding regions of proliferating cell nuclear antigen. J Biol Chem 269:11030, 1994
45. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 359:295, 1992
46. Lee EYHP, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288, 1992
47. Lee E, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K: Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8:2008, 1994
48. Kiyokawa H, Richon VM, Rifkind RA, Marks PA: Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14:7195, 1994
49. Copola JA, Lewis BA, Cole MD: Increased retinoblastoma gene expression is associated with late stages of differentiation in many cell types. Oncogene 5:1731, 1990
50. Aoki H, Takishita M, Kosaka M, Saito S: Frequent somatic mutations in D and/or Jh segments of Ig gene in Waldenstrom's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Blood 85:1913, 1995
51. Kuppers R, Ganse A, Rajewsky K: B cells of chronic lymphatic leukemia express V genes in unmutated form. Leuk Res 15:487, 1991
52. Wagner SD, Martinelli V, Luzzatto L: Similar patterns of Vk gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood 83:3647, 1994
53. Hummel M, Tamaru J, Kalvelage B, Stein H: Mantle cell (previously centrocytic) lymphomas express Vh genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 84:403, 1994